Barclay Buck A. Phillips
2018
In 2018, Barclay Buck A. Phillips earned a total compensation of $714.9K as Chief Financial Officer and Senior Vice President, Corporate Development at G1 Therapeutics, a 79% decrease compared to previous year.
Compensation breakdown
| Bonus | $120,000 |
|---|---|
| Non-Equity Incentive Plan | $156,695 |
| Salary | $370,000 |
| Other | $68,185 |
| Total | $714,880 |
Phillips received $370K in salary, accounting for 52% of the total pay in 2018.
Phillips also received $120K in bonus, $156.7K in non-equity incentive plan and $68.2K in other compensation.
Rankings
In 2018, Barclay Buck A. Phillips' compensation ranked 10,627th out of 14,244 executives tracked by ExecPay. In other words, Phillips earned more than 25.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,627 out of 14,244 | 25th |
Division Manufacturing | 4,280 out of 5,759 | 26th |
Major group Chemicals And Allied Products | 1,612 out of 2,122 | 24th |
Industry group Drugs | 1,361 out of 1,811 | 25th |
Industry Pharmaceutical Preparations | 1,046 out of 1,385 | 25th |
Source: SEC filing on April 30, 2019.
Phillips' colleagues
We found five more compensation records of executives who worked with Barclay Buck A. Phillips at G1 Therapeutics in 2018.